pemetrexed disodium

pemetrexed disodium

(pĕm′ĭ-trĕk′sĭd)
n.
A folic acid antagonist used in the treatment of nonsquamous non-small cell lung cancer and mesothelioma.
Mentioned in ?
References in periodicals archive ?
1,2) In addition to selection for predictive biomarker testing for targeted molecular therapy, the diagnosis of cell type by the pathologist is important for selection of therapy with bevacizumab and pemetrexed disodium.
The National Institute for Health and Clinical Excellence (Nice) made a U-turn after examining new evidence on pemetrexed disodium (Alimta).
Campaigners fighting for people with the lung disease mesothelioma wanted guidance changed on pemetrexed disodium (Alimta).